Colin Funk

Active 1971–2025

72
Papers
18,377
Citations
69
h-index
71
i10-index

Citations

Citations per year for Colin Funk1975: 1 citations1976: 1 citations1979: 2 citations1981: 4 citations1982: 1 citations1985: 6 citations1987: 2 citations1988: 2 citations1989: 13 citations1990: 24 citations1991: 28 citations1992: 37 citations1993: 34 citations1994: 63 citations1995: 70 citations1996: 89 citations1997: 93 citations1998: 106 citations1999: 111 citations2000: 147 citations2001: 183 citations2002: 228 citations2003: 219 citations2004: 237 citations2005: 212 citations2006: 240 citations2007: 229 citations2008: 200 citations2009: 222 citations2010: 196 citations2011: 203 citations2012: 160 citations2013: 178 citations2014: 193 citations2015: 148 citations2016: 108 citations2017: 137 citations2018: 112 citations2019: 331 citations2020: 378 citations2021: 352 citations2022: 267 citations2023: 156 citations2024: 230 citations2025: 110 citations1977–1978: no citations, so these years are not shown1980: no citations, so this year is not shown1983–1984: no citations, so these years are not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,259 citing papers, 35% of this breakdownChina: 498 citing papers, 7.7% of this breakdownGermany: 464 citing papers, 7.2% of this breakdownUnited Kingdom: 351 citing papers, 5.4% of this breakdownJapan: 298 citing papers, 4.6% of this breakdownCanada: 243 citing papers, 3.8% of this breakdownItaly: 236 citing papers, 3.6% of this breakdownFrance: 212 citing papers, 3.3% of this breakdownSweden: 178 citing papers, 2.7% of this breakdownSpain: 127 citing papers, 2% of this breakdownAustralia: 115 citing papers, 1.8% of this breakdownIndia: 115 citing papers, 1.8% of this breakdown
0%35%Other 21.1%

Fields

  • Medicine44%
  • Biochemistry, Genetics and Molecular Biology29.6%
  • Immunology and Microbiology9.9%
  • Nursing5%
  • Neuroscience3.3%
  • Agricultural and Biological Sciences2.4%
  • Other5.8%

Topics

  • Inflammatory mediators and NSAID effects6.8%
  • Eicosanoids and Hypertension Pharmacology5%
  • Peroxisome Proliferator-Activated Receptors3.2%
  • Fatty Acid Research and Health2.3%
  • Estrogen and related hormone effects2.2%
  • Asthma and respiratory diseases2%
  • Other78.5%

Coauthors

All papers

Open in search
  1. Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease

    Authors: , - Chemical Reviews 2011 cited by 864

  2. Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology

    Authors: - Science 2001 cited by 3,812

  3. Perivascular adipose tissue–derived extracellular vesicle miR‐221‐3p mediates vascular remodeling

    Authors: , , , - The FASEB Journal 2019 cited by 141

  4. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase

    Authors: , , , , , , , , , - Nature 1999 cited by 854

  5. Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice

    Authors: , , , , , , , , , , , - Science Translational Medicine 2012 cited by 233

  6. COX-2 Inhibitors and Cardiovascular Risk

    Authors: , - Journal of Cardiovascular Pharmacology 2007 cited by 332

  7. The Lamina Adventitia Is the Major Site of Immune Cell Accumulation in Standard Chow-Fed Apolipoprotein E–Deficient Mice

    Authors: , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2005 cited by 231

  8. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 164

  9. 12/15-Lipoxygenase Is Increased in Alzheimer's Disease

    Authors: , , , , , , , - American Journal Of Pathology 2004 cited by 242

  10. 5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null Mice

    Authors: , , , , , , , , , , - Hepatology 2009 cited by 108

  11. Arginase-1 deficiency

    Authors: , , , - Journal of Molecular Medicine 2015 cited by 103

  12. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice

    Authors: , , , , , , - Journal of Clinical Investigation 1999 cited by 521

  13. Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor

    Authors: , , , , , , , , , - Nature Medicine 1999 cited by 398

  14. Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice

    Authors: , , , , , - Circulation 2002 cited by 246

  15. Lipoxygenase genes and their targeted disruption

    Authors: , , , - Prostaglandins & Other Lipid Mediators 2002 cited by 195

  16. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease

    Authors: , - Cardiovascular Research 2010 cited by 188

  17. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 162

  18. EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2015 cited by 79

  19. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic

    Authors: , , - Frontiers in Pharmacology 2020 cited by 213

  20. Lipoxygenase Pathways in Atherogenesis

    Authors: , - Trends in Cardiovascular Medicine 2004 cited by 197

  21. Cyclooxygenase‐2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4)

    Authors: , , - The FASEB Journal 2013 cited by 89

  22. Mice Deficient in Cellular Glutathione Peroxidase Develop Normally and Show No Increased Sensitivity to Hyperoxia

    Authors: , , , , , , - Journal of Biological Chemistry 1997 cited by 560

  23. Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice

    Authors: , , , , , , , - Circulation Research 2002 cited by 421

  24. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2004 cited by 352